David Hallal - Director at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
KLRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Hallal since 31 Dec 2024

Holdings reported by David Hallal for Kalaris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,674,766 $13,211,417 $0.7923 06 Jun 2024 Shares held by ElevateBio LLC
Common Stock 2,143,662 $1,698,423 $0.7923 06 Jun 2024 Direct
Common Stock 720,965 $571,221 $0.7923 06 Jun 2024 Shares held by The Hallal Family Irrevocable Trust 2012
Common Stock 138,153 $109,459 $0.7923 06 Jun 2024 Shares held by Terrie A. Hallal Family Irrevocable Trust 2012
Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct Common Stock

Transactions reported by David Hallal for Kalaris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.